Lipid Metabolism Practice Questions

Q: Which of the following is produced by the complete oxidation of one molecule of palmitic acid in mitochondrial beta-oxidation?

7 FADH2, 7 NADH, and 8 acetyl-CoA molecules. **Explanation:** The complete oxidation of a fatty acid occurs via the **$\beta$-oxidation spiral** in the mitochondria. To determine the yield of Palmitic acid (a 16-carbon saturated fatty acid), we use two primary rules: 1. **Number of Acetyl-CoA molecules:** Since each Acetyl-CoA has 2 carbons, the yield is $C/2$. For Palmitate (C16), this results in **8 Acetyl-CoA** molecules ($16/2 = 8$). 2. **Number of Cycles:** The number of rounds of $\beta$-oxidation required is $(C/2) - 1$. For Palmitate, this is **7 cycles** ($8 - 1 = 7$). In each cycle of $\beta$-oxidation, one molecule of **FADH$_2$** (via acyl-CoA dehydrogenase) and one molecule of **NADH** (via 3-hydroxyacyl-CoA dehydrogenase) are produced. Therefore, 7 cycles yield **7 FADH$_2$ and 7 NADH**. The final cycle splits a 4-carbon unit (Butyryl-CoA) into two 2-carbon Acetyl-CoA molecules, which is why there is one less cycle than the total number of Acetyl-CoA produced. **Analysis of Incorrect Options:** * **Option A & C:** These suggest 8 cycles of oxidation. This is incorrect because the 8th Acetyl-CoA is produced automatically at the end of the 7th cycle without further oxidation. * **Option B:** This suggests only 7 Acetyl-CoA molecules are produced, which would only account for 14 carbons, leaving the 16-carbon Palmitate incomplete. **High-Yield NEET-PG Pearls:** * **Net ATP Yield:** The total ATP yield for Palmitate is **106 ATP** (108 generated minus 2 used for initial activation). * **Rate-Limiting Step:** The transport of long-chain fatty acids into the mitochondria via the **Carnitine Shuttle** (inhibited by Malonyl-CoA). * **Clinical Correlation:** Deficiency of **MCAD** (Medium-Chain Acyl-CoA Dehydrogenase) is the most common inborn error of $\beta$-oxidation, presenting as non-ketotic hypoglycemia during fasting.

Q: Which of the following is a scavenger of cholesterol from tissues and prevents atherosclerosis?

HDL. ### Explanation **Correct Option: D (HDL)** High-Density Lipoprotein (HDL) is known as the **"Good Cholesterol"** because of its role in **Reverse Cholesterol Transport**. It acts as a scavenger by picking up excess cholesterol from peripheral tissues and vascular walls and transporting it back to the liver for excretion in bile. This process is mediated by the enzyme **LCAT (Lecithin-Cholesterol Acyltransferase)**, which esterifies free cholesterol. By removing cholesterol from the arterial endothelium, HDL prevents the formation of foam cells and inhibits the progression of atherosclerosis. **Incorrect Options:** * **A (VLDL):** Produced by the liver, its primary role is to transport endogenous triglycerides to peripheral tissues. High levels are associated with increased cardiovascular risk, not protection. * **B (LDL):** Known as **"Bad Cholesterol,"** LDL transports cholesterol *from* the liver *to* the peripheral tissues. High levels lead to cholesterol deposition in arterial walls, leading to atherosclerosis. * **C (Chylomicrons):** These are responsible for transporting exogenous (dietary) lipids from the intestines to the liver and peripheral tissues. They are primarily composed of triglycerides. **NEET-PG High-Yield Pearls:** * **Apo A-I:** The major apoprotein associated with HDL; it activates LCAT. * **CETP (Cholesteryl Ester Transfer Protein):** Facilitates the exchange of cholesteryl esters from HDL for triglycerides from VLDL/LDL. * **Tangier Disease:** A rare genetic disorder characterized by a deficiency in the **ABCA1 transporter**, leading to extremely low HDL levels and orange-colored tonsils. * **Protective Level:** An HDL level >60 mg/dL is considered a "negative" risk factor for coronary heart disease.

Q: What is the most important predictor of coronary artery disease?

HDL. **Explanation:** The correct answer is **HDL (High-Density Lipoprotein)**. In clinical practice and biochemistry, the level of HDL is considered the most significant independent predictor of Coronary Artery Disease (CAD). **1. Why HDL is the correct answer:** HDL is known as "Good Cholesterol" because it facilitates **Reverse Cholesterol Transport**. It picks up excess cholesterol from peripheral tissues and vascular endothelium and transports it back to the liver for excretion in bile. High levels of HDL are **cardioprotective** because they prevent the formation of foam cells and atherosclerotic plaques. Conversely, low HDL levels are the strongest lipid predictor of increased cardiovascular risk. **2. Why the other options are incorrect:** * **VLDL (Very Low-Density Lipoprotein):** Primarily transports endogenous triglycerides. While elevated VLDL contributes to metabolic syndrome, it is not as strong a predictor as HDL or LDL. * **LDL (Low-Density Lipoprotein):** Known as "Bad Cholesterol," it transports cholesterol to peripheral tissues. While high LDL is a major risk factor and the primary target for statin therapy, statistically, low HDL is often a more sensitive predictor of future cardiac events. * **Chylomicron:** These transport dietary (exogenous) triglycerides. They are not directly atherogenic; their primary clinical significance relates to pancreatitis when levels are extremely high. **Clinical Pearls for NEET-PG:** * **Apo A-I** is the major apoprotein associated with HDL (anti-atherogenic). * **Apo B-100** is the major apoprotein associated with VLDL and LDL (atherogenic). * **Friedewald Formula:** LDL = Total Cholesterol – (HDL + TG/5). (Note: This is invalid if TG >400 mg/dL). * **The Best Ratio:** The Total Cholesterol/HDL ratio is often used in risk scoring; a higher ratio indicates a higher risk of CAD.

Q: Apolipoprotein A is a major component of which lipoprotein particle?

High-density lipoprotein (HDL). **Explanation:** The correct answer is **High-density lipoprotein (HDL)**. Apolipoprotein A (specifically **Apo A-I**) is the primary structural protein of HDL, accounting for approximately 70% of its protein content. It plays a critical role in **Reverse Cholesterol Transport** by acting as a cofactor for the enzyme **LCAT (Lecithin-Cholesterol Acyltransferase)**, which esterifies free cholesterol, allowing it to be packed into the core of the HDL particle for transport to the liver. **Analysis of Incorrect Options:** * **Chylomicrons:** Their characteristic structural protein is **Apo B-48**. While they do contain some Apo A-I (acquired from the intestine), it is rapidly transferred to HDL in the circulation. * **VLDL:** The primary structural protein for VLDL is **Apo B-100**. It also contains Apo C-II (activates Lipoprotein Lipase) and Apo E. * **LDL:** Formed from the metabolism of VLDL, LDL contains only **Apo B-100**, which serves as the ligand for the LDL receptor. **High-Yield Clinical Pearls for NEET-PG:** * **Apo A-I:** Activates **LCAT** (Reverse Cholesterol Transport). * **Apo B-48:** Required for chylomicron assembly and secretion from the intestine. * **Apo B-100:** Required for VLDL assembly and acts as a ligand for the **LDL receptor**. * **Apo C-II:** A potent activator of **Lipoprotein Lipase (LPL)**. * **Apo E:** Mediates the uptake of chylomicron remnants and IDL by the liver. * **Tangier Disease:** A rare genetic disorder characterized by a deficiency of the ABCA1 transporter, leading to extremely low levels of HDL and Apo A-I.

Q: Which of the following is an omega-3 fatty acid?

Cervonic acid. **Explanation:** Fatty acids are classified based on the position of the first double bond from the methyl ($\omega$) end. **Omega-3 ($\omega$-3) fatty acids** have their first double bond at the third carbon atom from the methyl terminal. **Why Cervonic Acid is Correct:** **Cervonic acid** is the systematic name for **Docosahexaenoic acid (DHA)** ($22:6, \omega\text{-}3$). It is a long-chain polyunsaturated fatty acid (PUFA) essential for retinal and brain development. Since the first double bond occurs at the third carbon from the $\omega$-end, it is a classic $\omega$-3 fatty acid. **Analysis of Incorrect Options:** * **Linoleic acid ($18:2, \omega\text{-}6$):** This is an essential fatty acid, but it belongs to the **$\omega$-6 family**. It is the precursor for arachidonic acid. * **Arachidonic acid ($20:4, \omega\text{-}6$):** Derived from linoleic acid, this is an **$\omega$-6 fatty acid**. It serves as a precursor for pro-inflammatory eicosanoids (prostaglandins and leukotrienes). * **Oleic acid ($18:1, \omega\text{-}9$):** This is a monounsaturated fatty acid (MUFA) commonly found in olive oil. It belongs to the **$\omega$-9 family**. **High-Yield NEET-PG Pearls:** 1. **Essential Fatty Acids (EFA):** Humans lack enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) to introduce double bonds beyond carbon 9. Thus, Linoleic ($\omega$-6) and $\alpha$-Linolenic acid ($\omega$-3) must be obtained from the diet. 2. **$\omega$-3 Family Members:** Includes $\alpha$-Linolenic acid (ALA), Timnodonic acid (EPA), and Cervonic acid (DHA). 3. **Clinical Significance:** $\omega$-3 fatty acids are cardioprotective as they decrease serum triglycerides and inhibit VLDL synthesis. 4. **Nomenclature Tip:** **Cervonic** acid (DHA) is often confused with **Clupanodonic** acid (DPA - also an $\omega$-3). Both are high-yield terms in lipid biochemistry.

Q: Which is the best marker of dyslipidemia?

LDL/HDL ratio. **Explanation:** The **LDL/HDL ratio** is considered the best marker of dyslipidemia because it reflects the balance between "bad" cholesterol (pro-atherogenic) and "good" cholesterol (anti-atherogenic). While individual lipid levels provide data, the ratio offers a superior predictive value for cardiovascular risk. A high ratio indicates that the rate of cholesterol deposition in peripheral tissues (mediated by LDL) significantly outweighs the rate of reverse cholesterol transport (mediated by HDL). **Analysis of Options:** * **Option A & C (Triglycerides and Cholesterol):** These are absolute values. While elevated levels are risk factors, they do not account for the protective effect of HDL. For example, a patient with high total cholesterol but very high HDL may have a lower cardiovascular risk than someone with "normal" cholesterol but very low HDL. * **Option D (Apolipoprotein AI):** Apo-AI is the primary protein component of HDL. While it is a good marker for the number of HDL particles, it is only one side of the lipid equation and is less comprehensive than the LDL/HDL ratio in clinical practice. **Clinical Pearls for NEET-PG:** * **Atherogenic Index of Plasma (AIP):** Calculated as $log(TG/HDL-C)$. It is an emerging potent marker for atherosclerosis. * **Friedewald Formula:** Used to calculate LDL ($LDL = Total\ Cholesterol – HDL – TG/5$). Note: This formula is inaccurate if $TG > 400\ mg/dL$. * **Apo B:** Often cited as a better predictor of cardiovascular events than LDL-C alone because it measures the total number of atherogenic particles (LDL, VLDL, IDL). * **Target Ratio:** For primary prevention, an LDL/HDL ratio **< 3.0** is generally considered desirable.

Q: Which lipoprotein is the predominant carrier of cholesterol in the blood?

LDL and HDL. **Explanation:** Lipoproteins are classified based on their density and the specific lipids they transport. To identify the predominant carriers of cholesterol, one must distinguish between exogenous/endogenous triglycerides and cholesterol esters. **1. Why LDL and HDL are correct:** * **LDL (Low-Density Lipoprotein):** Known as "bad cholesterol," LDL is the primary carrier of cholesterol from the liver to peripheral tissues. It contains the highest percentage of cholesterol (approx. 50%) among all lipoproteins. * **HDL (High-Density Lipoprotein):** Known as "good cholesterol," it is responsible for **Reverse Cholesterol Transport**, carrying excess cholesterol from peripheral tissues back to the liver. Together, these two fractions account for the vast majority of cholesterol circulating in the plasma. **2. Why other options are incorrect:** * **Chylomicrons:** These primarily transport **exogenous (dietary) triglycerides** from the intestines to the tissues. * **VLDL (Very Low-Density Lipoprotein):** These primarily transport **endogenous triglycerides** synthesized in the liver. * **IDL (Intermediate-Density Lipoprotein):** A transient state in the conversion of VLDL to LDL; while it contains cholesterol, its concentration in the blood is normally very low. **Clinical Pearls for NEET-PG:** * **Apo-B100** is the characteristic apolipoprotein for VLDL, IDL, and LDL. * **Apo-A1** is the primary apolipoprotein for HDL. * **Friedewald Equation:** LDL Cholesterol = Total Cholesterol – [HDL + (Triglycerides/5)]. (Note: This is invalid if TG >400 mg/dL). * **Rate-limiting enzyme** for cholesterol synthesis: HMG-CoA Reductase (target of Statins).

Q: The PAN-SH site of the fatty acid synthase complex accepts which of the following?

Malonyl CoA. **Explanation:** The **Fatty Acid Synthase (FAS) complex** is a multi-enzyme system that functions as a dimer. Each monomer contains two essential thiol (-SH) groups: 1. **Cys-SH:** Located on the 3-ketoacyl synthase (condensing enzyme) subunit. 2. **Pan-SH:** Located on the **Acyl Carrier Protein (ACP)** subunit, derived from the prosthetic group 4'-phosphopantetheine. **Why Malonyl CoA is correct:** During the elongation cycle of fatty acid synthesis, the **Pan-SH** site is the primary "loading dock" for the 3-carbon donor, **Malonyl CoA**. The enzyme *Malonyl acetyl transacylase* catalyzes the transfer of the malonyl group to the Pan-SH group of ACP. While the very first Acetyl CoA molecule initially binds to Pan-SH, it is immediately transferred to the Cys-SH site to vacate Pan-SH for the incoming Malonyl CoA. Therefore, in the repetitive cycles of synthesis, Pan-SH specifically accepts Malonyl CoA. **Analysis of Incorrect Options:** * **Acetyl CoA:** This acts as the "primer" or "starter" molecule. While it briefly touches Pan-SH, its functional residence during the condensation reaction is the **Cys-SH** site. * **Propionyl CoA:** This is used as a primer only for the synthesis of odd-chain fatty acids (rare in humans). It does not represent the standard substrate for the FAS complex Pan-SH site in general metabolism. **High-Yield Facts for NEET-PG:** * **Rate-limiting step:** The conversion of Acetyl CoA to Malonyl CoA by *Acetyl CoA Carboxylase (ACC)*, which requires **Biotin**. * **End product:** The FAS complex primarily produces **Palmitate** (a 16-carbon saturated fatty acid). * **Reductant:** **NADPH** is the essential electron donor, primarily sourced from the Hexose Monophosphate (HMP) shunt. * **Location:** Fatty acid synthesis occurs in the **Cytosol** (the "Citrate-Malate Shuttle" transports Acetyl CoA out of the mitochondria).

Question 1

A young man participates in a nutritional research study. After ingesting a very fatty meal, serum samples are taken for research studies at 1 hour and 3 hours. The studies measure the average diameter of chylomicrons, showing an average diameter of 500 nm at 1 hour, which drops to an average diameter of 150 nm at 3 hours. Where is the enzyme responsible for this change primarily located?

Accepted Answer

Endothelial cells

Answer

Adipocytes

Answer

Enterocytes

Answer

Hepatocytes

Question 2

Which of the following is produced by the complete oxidation of one molecule of palmitic acid in mitochondrial beta-oxidation?

Accepted Answer

7 FADH2, 7 NADH, and 8 acetyl-CoA molecules

Answer

8 FADH2, 8 NADH, and 8 acetyl-CoA molecules

Answer

7 FADH2, 7 NADH, and 7 acetyl-CoA molecules

Answer

8 FADH2, 8 NADH, and 7 acetyl-CoA molecules

Question 3

Which of the following is a scavenger of cholesterol from tissues and prevents atherosclerosis?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

Chylomicrons

Question 4

Respiratory distress syndrome in premature infants is due to inadequate secretion of which one of the following lipids?

Accepted Answer

Dipalmitoyl phosphatidycholine

Answer

Sphingomyelin

Answer

Cholesterol

Answer

Phosphatidylinositol

Question 5

What is the most important predictor of coronary artery disease?

Accepted Answer

HDL

Answer

VLDL

Answer

LDL

Answer

Chylomicron

Question 6

Apolipoprotein A is a major component of which lipoprotein particle?

Accepted Answer

High-density lipoprotein (HDL)

Answer

Chylomicrons

Answer

Very-low-density lipoprotein (VLDL)

Answer

Low-density lipoprotein (LDL)

Question 7

Which of the following is an omega-3 fatty acid?

Accepted Answer

Cervonic acid

Answer

Linoleic acid

Answer

Arachidonic acid

Answer

Oleic acid

Question 8

Which is the best marker of dyslipidemia?

Accepted Answer

LDL/HDL ratio

Answer

Triglycerides and cholesterol

Answer

Cholesterol

Answer

Apolipoprotein AI

Question 9

Which lipoprotein is the predominant carrier of cholesterol in the blood?

Accepted Answer

LDL and HDL

Answer

HDL and VLDL

Answer

Chylomicron and VLDL

Answer

IDL and HDL

Question 10

The PAN-SH site of the fatty acid synthase complex accepts which of the following?

Accepted Answer

Malonyl CoA

Answer

Acetyl CoA

Answer

Propionyl CoA

Answer

All of the above

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?